Skip to main content
رجوع
ARGX logo

argenx SE

جودة البيانات: 100%
ذروة بيع
ARGX
NASDAQ Healthcare Biotechnology
KWD 677.50
▼ KWD 4.35 (-0.64%)
القيمة السوقية: 41.93B
مُدرج أيضًا باسم ARGNF OTC
نطاق اليوم
KWD 666.79 KWD 677.85
نطاق 52 أسبوعًا
KWD 510.06 KWD 934.62
حجم التداول
256,342
متوسط 50 يوم / 200 يوم
KWD 791.83 / KWD 749.96
الإغلاق السابق
KWD 681.85

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E 32.4 0.3
P/B 5.7 2.9
ROE % 20.2 3.7
Net Margin % 31.1 3.8
Rev Growth 5Y % 70.1 10.0
D/E 0.0 0.2

السعر المستهدف للمحللين

Hold
KWD 1,026.710 +51.5%
Low: KWD 858.000 High: KWD 1,317.000
مكرر الربحية المستقبلي
25.8
ربحية السهم المستقبلية
KWD 26.473
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
6 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 59.471
KWD 51.802 – KWD 67.364
11 B 5
FY2029 KWD 51.946
KWD 45.248 – KWD 58.840
9.8 B 11
FY2028 KWD 45.304
KWD 39.462 – KWD 51.317
8.5 B 9

النقاط الرئيسية

Revenue grew 70.11% annually over 5 years — strong growth
Earnings grew 55.58% over the past year
ROE of 20.22% indicates high profitability
Net margin of 31.12% shows strong profitability
Debt/Equity of 0.01 — conservative balance sheet
Generating 844.30M in free cash flow

النمو

Revenue Growth (5Y)
70.11%
Revenue (1Y)90.12%
Earnings (1Y)55.58%
FCF Growth (3Y)N/A

الجودة

Return on Equity
20.22%
ROIC9.85%
Net Margin31.12%
Op. Margin23.35%

الأمان

Debt / Equity
0.01
Current Ratio5.23
Interest Coverage237.50

التقييم

P/E Ratio
32.35
P/B Ratio5.73
EV/EBITDA39.61
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 90.12% Revenue Growth (3Y) 84.27%
Earnings Growth (1Y) 55.58% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 70.11% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4.16B Net Income (TTM) 1.30B
ROE 20.22% ROA 14.93%
Gross Margin 89.14% Operating Margin 23.35%
Net Margin 31.12% Free Cash Flow (TTM) 844.30M
ROIC 9.85% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.01 Current Ratio 5.23
Interest Coverage 237.50 Dividend Yield 0.00%
Valuation
P/E Ratio 32.35 P/B Ratio 5.73
P/S Ratio 10.07 PEG Ratio 0.77
EV/EBITDA 39.61 Dividend Yield 0.00%
Market Cap 41.93B Enterprise Value 38.52B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 4.16B 2.19B 1.23B 410.75M 497.28M
Net Income 1.30B 833.04M -295.05M -709.59M -407.63M
EPS (Diluted) 19.63 12.78 -5.16 -13.05 -7.99
Gross Profit 3.71B 1.96B 1.11B 381.32M 497.28M
Operating Income 972.46M -21.65M -425.05M -720.34M -348.75M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8.68B 6.20B 4.54B 3.13B 2.85B
Total Liabilities 1.36B 704.24M 444.95M 320.56M 316.05M
Shareholders' Equity 7.32B 5.50B 4.10B 2.81B 2.53B
Total Debt 83.49M 39.05M 20.00M 12.43M 11.47M
Cash & Equivalents 3.49B 1.50B 2.05B 800.74M 1.33B
Current Assets 6.90B 4.88B 4.12B 2.77B 2.54B
Current Liabilities 1.32B 669.92M 422.99M 302.28M 301.24M

درجات الاستراتيجيات

This stock passed the criteria for 3 strategies

Score = fit strength (0–100)
Rank = position among all matches
#41 of 157
74
Custom Full Throttle
#13 of 146
69
Custom Lower Risk
#39 of 140
52

النشاط الأخير

دخل Growth Investing (Philip Fisher)
Mar 24, 2026
دخل Full Throttle
Mar 24, 2026
دخل Lower Risk
Mar 24, 2026